BaroFold

BaroFold is a privately held biopharmaceutical company focused on developing commercially attractive protein therapies for immunological indications. The company aims to discover, develop, and commercialize protein biologics, some of which incorporate its proprietary PreEMT™ high-pressure folding technology along with other state-of-the-art techniques. The pipeline includes treatments with an immunological focus, including multiple sclerosis, rheumatoid arthritis, and asthma.